Telavancin clinical trials
Also written VIBATIV and TD-6424.
How each study uses telavancin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the telavancin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 11 Sept 2009 · VIBATIV · NDA 022110 (FDA, Drugs@FDA)
- European Union
- 2 Sept 2011 · Vibativ · EMEA/H/C/001240 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2005 (4)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 5
Cumberland Pharmaceuticals (10) · M.D. Anderson Cancer Center (1) · Joseph L. Kuti, PharmD (1) · University of Michigan (1) · University of Illinois at Chicago (1) · Aaron Cook (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test telavancin.
- Dec 2026Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular DrainagePhase 4 · Aaron Cook
Studies
Open first, then newest update. How each study uses telavancin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular DrainageRecruitingPhase 4Aaron CookNCT06119061Written as Telavancin InjectionHow we know
- Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)TerminatedPhase 1Cumberland PharmaceuticalsNCT02013141Written as TelavancinHow we know
- A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialTerminatedPhase 3Cumberland PharmaceuticalsNCT02208063Written as TelavancinHow we know
- Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer PatientsCompletedPhase 2M.D. Anderson Cancer CenterNCT01321879Written as TelavancinHow we know
- Telavancin Pharmacokinetics in Cystic Fibrosis PatientsCompletedPhase 4Joseph L. Kuti, PharmDNCT03172793Written as Telavancin InjectionHow we know
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00124020Written as TelavancinHow we know
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00091819Written as TelavancinHow we know
- Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedPhase 2Cumberland PharmaceuticalsNCT00077675Written as TelavancinHow we know
- Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00107952Written as TelavancinHow we know
- Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedPhase 2Cumberland PharmaceuticalsNCT00061633Written as TelavancinHow we know
- Telavancin for Treatment of Uncomplicated Staphylococcus Aureus BacteremiaCompletedPhase 2Cumberland PharmaceuticalsNCT00062647Written as TelavancinHow we know
- Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus AureusCompletedPhase 3Cumberland PharmaceuticalsNCT00107978Written as TelavancinHow we know
- A Study to Evaluate the Effect of Renal Function on the Biological Activity of TelavancinCompletedPhase 1Cumberland PharmaceuticalsNCT01238796Written as telavancinHow we know
- Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5CompletedPhase 4University of MichiganNCT02392208Written as TelavancinHow we know
- Pharmacokinetics of Telavancin in Normal and Obese SubjectsCompletedPhase 1University of Illinois at ChicagoNCT02753855Written as TelavancinHow we know
Codes
What other systems call telavancin · ClinicalTrials.gg INT004664
- MeSH (NLM) C487637telavancinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) XK134822Z0TELAVANCINConfirmed FDA, NLM, Wikidata
- RxNorm 473837Confirmed FDA, Wikidata
- Wikidata Q7695658telavancinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87603TelavancinOne source FDA
- DrugBank DB06402One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C487637 | telavancin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | XK134822Z0 | TELAVANCIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 473837 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7695658 | telavancin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87603 | Telavancin | One source FDA |
| DrugBank | DB06402 | — | One source Wikidata |
Also registered as telavancin hydrochloride (UNII 0701472ZG0 · RxNorm 864624).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.